X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 1-methyl-7-nitro-5-phenyl-1,3-dihydro-2h-1,4- Benzodiazepin-2-one
2. Hypnon
3. S-1530
1. 2011-67-8
2. 1-methylnitrazepam
3. Elimin
4. Erimin
5. Methylnitrazepam
6. 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2h-1,4-benzodiazepin-2-one
7. Nimetazepamum
8. Ro 5-3453
9. S 1530
10. 1-methyl-5-phenyl-7-nitro-1,3-dihydro-2h-1,4-benzodiazepin-2-one
11. 1-methyl-7-nitro-5-phenyl-1,3-dihydro-2h-1,4-benzodiazepin-2-one
12. 1-methyl-7-nitro-5-phenyl-3h-1,4-benzodiazepin-2-one
13. S-1530
14. 2h-1,4-benzodiazepin-2-one, 1,3-dihydro-1-methyl-7-nitro-5-phenyl-
15. Chebi:31912
16. Ncgc00164577-01
17. 4532264kw6
18. Dsstox_cid_3369
19. Dsstox_rid_76997
20. Dsstox_gsid_23369
21. Nimetazepam [inn:jan]
22. Nimetazepamum [inn-latin]
23. Smr000238177
24. Cas-2011-67-8
25. Einecs 217-931-5
26. Brn 0759813
27. Dormalon
28. Dea No. 2837
29. Unii-4532264kw6
30. Erimin (tn)
31. Nitrazepam, Methylated
32. Nimetazepam (jan/inn)
33. Nimetazepam [mi]
34. Nimetazepam [inn]
35. Nimetazepam [jan]
36. Nimetazepam [mart.]
37. Schembl79886
38. Nimetazepam [who-dd]
39. Mls000759521
40. Mls001424150
41. Chembl13341
42. Dtxsid6023369
43. Hms2051l16
44. Hms3393l16
45. Zinc3831205
46. Tox21_112205
47. Akos030239804
48. Tox21_112205_1
49. Ccg-101044
50. Nc00294
51. Ncgc00164577-02
52. D01593
53. 011n678
54. A814257
55. Q6149812
56. 1-methyl-7-nitro-5-phenyl-2,3-dihydro-1h-1,4-benzodiazepin-2-one
57. 7-nitro-1,3-dihydro-1-methyl-5-phenyl-2h-1,4-benzodiazepin-2-one
58. Nimetazepam Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 295.29 g/mol |
|---|---|
| Molecular Formula | C16H13N3O3 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 295.09569129 g/mol |
| Monoisotopic Mass | 295.09569129 g/mol |
| Topological Polar Surface Area | 78.5 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 480 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
N - Nervous system
N05 - Psycholeptics
N05C - Hypnotics and sedatives
N05CD - Benzodiazepine derivatives
N05CD15 - Nimetazepam
Market Place
